中文
About Us
Corporate Overview
Management Team
Board of Directors
Contact Us
Our Focus
Metabolic Diseases
Viral Diseases
Cancer
Exploratory Indications
Products&Pipeline
Pipeline
Products
Clinical Trials
Partnership
Investors
Financials & Filing
Presentation Materials
News
Careers
Investors
Financials & Filing
Presentation Materials
2024
2023
2022
2021
2020
2019
2018
2024
2023
2022
2021
2020
2019
2018
Next Day Disclosure Returns - Share Buyback
2024-09-25
Next Day Disclosure Returns - Share Buyback
2024-09-24
Announcement - Change in Use of Proceeds
2024-09-23
Voluntary Announcement - Ascletis Enters the Obesity Drug Space with Announcement of Two Ongoing U.S. Phase I Clinical Trials Utilizing Its Small Molecule GLP-1R Agonist ASC30 for Both Once-Monthly Subcutaneous Injection and Once-Daily Oral Tablet for the
2024-09-17
Next Day Disclosure Returns - Share Buyback
2024-09-17
Next Day Disclosure Returns - Share Buyback
2024-09-16
Next Day Disclosure Returns - Share Buyback
2024-09-11
Next Day Disclosure Returns - Share Buyback
2024-09-09
Next Day Disclosure Returns - Share Buyback
2024-09-05
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2024
2024-09-02
«
1
2
3
4
»
浙公网安备 33010802003344号
浙ICP备11050387号-1
